Release Date: 13/03/18 09:50 Summary: OVERSUBSCRIBED SHARE PLACEMENT TO RAISE $3,000,000 Price Sensitive: Yes Download Document 289.54KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%